# Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines

> **NCT00121823** · PHASE1,PHASE2 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 120 (—)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** FP9 ME-TRAP
- **BIOLOGICAL:** MVA ME-TRAP

## Key facts

- **NCT ID:** NCT00121823
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 120 (—)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121823, "Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00121823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*